Leticia P. de Oliveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Leticia P. de Oliveira has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Wendell Guerra
Institute of Chemistry, Federal University of Uberlândia, Santa Mônica Campus, Uberlândia, Minas Gerais 38400-902, Brazil
4 shared publications Drielly A. Paixão
3 shared publications- Carla Duque Lopes
Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
2 shared publications Joana Darc S. Chaves
Departamento de Química, Universidade Federal de Juiz de Fora, Juiz de Fora-MG, Brazil
2 shared publications- Luana M. Sousa
Instituto de Química, Universidade Federal de Uberlândia, Campus Santa Mônica, Uberlândia, MG, Brazil
2 shared publications - Marcos Pivatto
Nucleus of Research on Bioactive Compounds (NPCBio), Institute of Chemistry, Federal University of Uberlândia
2 shared publications
Latest Publications
- 1 January 2026
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
Synthesis, Crystal Structure, Cell Viability and in vitro Antiviral Activities Over Arboviruses of Novel Adamantane-Derived Schiff Bases
Arboviral diseases such as Zika, Mayaro and chikungunya fevers are neglected infections transmitted by arthropod vectors. The search for alternatives to circumvent the effects of arboviruses by modifying molecules previously known for their antiviral activities can be considered a good strategy to obtain new antiviral drugs. Here, we describe the synthesis of novel adamantane‑derived Schiff bases and their antiviral activities against Zika (ZIKV), Mayaro (MAYV) and chikungunya (CHIKV) viruses. Amantadine Schiff base was prepared by reaction of amantadine and 2-thiophenecarboxyaldehyde (atdTiof), while rimantadine Schiff base was prepared by reaction of rimantadine and 5-fluoro-2-hydroxybenzaldehyde (rtdFhba). The compositions of the Schiff bases were determined by elemental and mass spectrometric analyses as C15H19NS and C19H24FNO for atdTiof and rtdFhba, respectively. Spectroscopic characterizations added to single crystal X-ray diffraction permitted proposing the structures of Schiff bases. Cell viability and antiviral activities of the compounds were evaluated against ZIKV, MAYV and CHIKV viruses. The atdTiof and rtdFhba species exhibited the best inhibition rates of 58.5% over ZIKV and 69.5% over CHIKV, respectively. The results obtained in the in vitro studies open perspectives for future in vivo investigations of the synthesized Schiff bases in the search for alternatives for the treatment of arboviruses.
- 1 January 2026
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
Synthesis, Crystal Structure, Cell Viability and in vitro Antiviral Activities Over Arboviruses of Novel Adamantane-Derived Schiff Bases
Arboviral diseases such as Zika, Mayaro and chikungunya fevers are neglected infections transmitted by arthropod vectors. The search for alternatives to circumvent the effects of arboviruses by modifying molecules previously known for their antiviral activities can be considered a good strategy to obtain new antiviral drugs. Here, we describe the synthesis of novel adamantane‑derived Schiff bases and their antiviral activities against Zika (ZIKV), Mayaro (MAYV) and chikungunya (CHIKV) viruses. Amantadine Schiff base was prepared by reaction of amantadine and 2-thiophenecarboxyaldehyde (atdTiof), while rimantadine Schiff base was prepared by reaction of rimantadine and 5-fluoro-2-hydroxybenzaldehyde (rtdFhba). The compositions of the Schiff bases were determined by elemental and mass spectrometric analyses as C15H19NS and C19H24FNO for atdTiof and rtdFhba, respectively. Spectroscopic characterizations added to single crystal X-ray diffraction permitted proposing the structures of Schiff bases. Cell viability and antiviral activities of the compounds were evaluated against ZIKV, MAYV and CHIKV viruses. The atdTiof and rtdFhba species exhibited the best inhibition rates of 58.5% over ZIKV and 69.5% over CHIKV, respectively. The results obtained in the in vitro studies open perspectives for future in vivo investigations of the synthesized Schiff bases in the search for alternatives for the treatment of arboviruses.
- 1 September 2019
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1192, 76-81
Pt(II) complexes of the type trans-[PtCl2(DMSO) (hydrazide)] and cis-[PtCl2(hydrazide)2]: Solvolysis and cytotoxic activity
- 1 September 2019
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1192, 76-81
Pt(II) complexes of the type trans-[PtCl2(DMSO) (hydrazide)] and cis-[PtCl2(hydrazide)2]: Solvolysis and cytotoxic activity
- Open Access
- 1 January 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 109, 157-166
In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
- 1 January 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 109, 157-166
Open AccessIn vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
- Open Access
- 1 November 2018
- Published by Springer Nature in Journal of Saudi Chemical Society
- Vol. 22 (7) , 809-815
Crystal structure of two new polymeric copper(II) complexes active against Trypanosoma cruzi
- 1 November 2018
- Published by Springer Nature in Journal of Saudi Chemical Society
- Vol. 22 (7) , 809-815
Open AccessCrystal structure of two new polymeric copper(II) complexes active against Trypanosoma cruzi
- 1 June 2018
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 183, 77-83
Three new platinum complexes containing fluoroquinolones and DMSO: Cytotoxicity and evaluation against drug-resistant tuberculosis
- 1 June 2018
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 183, 77-83
Three new platinum complexes containing fluoroquinolones and DMSO: Cytotoxicity and evaluation against drug-resistant tuberculosis